RUTH TURNER: Open Payments
NPI 1659793883 · O FALLON, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,895 in 73 payments from 18 companies in 2025. Trend: 2023 $1,867 · 2024 $1,511 · 2025 $1,895
Food & beverage: $1,786Education: $109
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $368 |
| Regeneron Healthcare Solutions, Inc. | 13 | $297 |
| Novartis Pharmaceuticals Corporation | 5 | $236 |
| GlaxoSmithKline, LLC. | 10 | $202 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $148 |
| GENZYME CORPORATION | 7 | $126 |
| CSL Behring | 4 | $83 |
| Azurity Pharmaceuticals, Inc. | 4 | $68 |
| SANOFI-AVENTIS U.S. LLC | 1 | $60 |
| HOSPIRA, INC. | 2 | $59 |
Products named: DUPIXENT, FASENRA, NUCALA, NEFFY, Rhapsido, OCTAGAM IMMUNE GLOBULIN (HUMAN), Hizentra, ALVESCO.
Industry payments across MO — which companies pay providers there.
